Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07890428Phase 1Not yet recruiting
Phase 1, randomised, double-blind trial of phenytoin in Oral ulcer, oral mucositis (OM) and aphthous stomatitis (RAS) (2 arms), sponsored by Misr University for Science and Technology. Primary endpoint: Incidence of Treatment-Emergent Adverse Events at 7 days. Planned start Oct 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07890428.